Quick Summary Deal Value: Biogen partners with Neomorph in a deal worth up to $1.45 billion. Focus: Development of molecular glue degraders for cancer and
Quick Summary Deal Value: AbbVie acquires Aliada Therapeutics for $1.4 billion. Strategic Focus: Expands AbbVie’s central nervous system (CNS) and oncology capabilities. Therapeutic Goals: Strengthening
Merck & Co. has acquired Modifi Biosciences, a precision oncology biotech, in a deal that includes a $30 million upfront payment and potential milestones totaling
